标题
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 8, Issue 7, Pages 934
出版商
MDPI AG
发表日期
2019-06-28
DOI
10.3390/jcm8070934
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of KPC variant and porin genotype on the in vitro activity of meropenem-vaborbactam against carbapenem-resistant Enterobacteriaceae
- (2019) William R. Wilson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from United States Hospitals and Comparative Activity of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
- (2018) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-resistant Enterobacteriaceae
- (2018) M. Thwaites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
- (2018) David R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
- (2018) Yutaka Saisho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment
- (2018) Christopher M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime/avibactam, Meropenem/vaborbactam or both? Clinical and formulary considerations
- (2018) Jason M Pogue et al. CLINICAL INFECTIOUS DISEASES
- New antibiotics for ventilator-associated pneumonia
- (2018) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam – epidemiology, laboratory detection and treatment implications
- (2018) Norelle Sherry et al. Expert Review of Anti-Infective Therapy
- In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme
- (2018) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection
- (2018) Keith S. Kaye et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection
- (2018) Fusun Can et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
- (2018) Paolo Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae
- (2018) Yong-Qiang Yang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Criteria for Selecting Suitable Infectious Diseases for Phage Therapy
- (2018) David Harper Viruses-Basel
- Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
- (2018) Frank Oechslin Viruses-Basel
- Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae
- (2018) Xiaoming Wang et al. Emerging Microbes & Infections
- Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
- (2018) Joseph V. Newman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae
- (2018) Jin-xin Zheng et al. Emerging Microbes & Infections
- Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
- (2018) Lindsay Petty et al. Infection and Drug Resistance
- Optimizing therapy in CRE infections
- (2018) Mario Tumbarello et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing
- (2018) Christopher M. Bland et al. PHARMACOTHERAPY
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship
- (2017) Maria Adriana Cataldo et al. Expert Review of Anti-Infective Therapy
- Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
- (2017) Anna Both et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae
- (2017) Aurélie Jayol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
- (2017) Valérie Denervaud-Tendon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of colistin resistance in Enterobacter aerogenes from Croatia
- (2017) Branka Bedenić et al. JOURNAL OF CHEMOTHERAPY
- Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
- (2017) Ryan K. Shields et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?
- (2017) B. Davido et al. JOURNAL OF HOSPITAL INFECTION
- Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1 -positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study
- (2017) Yang Wang et al. LANCET INFECTIOUS DISEASES
- Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance
- (2017) Huseyin Guducuoglu et al. Microbial Drug Resistance
- Tigecycline Susceptibility and Molecular Resistance Mechanisms Among Clinical Klebsiella pneumoniae Strains Isolated During Non-Tigecycline Treatment
- (2017) Ruilian Li et al. Microbial Drug Resistance
- Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258
- (2017) Valéria Szijártó et al. Virulence
- A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World
- (2017) Michael P. Motley et al. mSphere
- Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
- (2016) Tsukasa Ito-Horiyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
- (2016) Vincenzo Di Pilato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae
- (2016) Elizabeth Diago-Navarro et al. Clinical and Vaccine Immunology
- Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
- (2016) Laura J. Rojas et al. CLINICAL INFECTIOUS DISEASES
- Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections
- (2016) E. Durante-Mangoni et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- Presence ofmcr-1-positiveEnterobacteriaceaein retail chicken meat but not in humans in the Netherlands since 2009
- (2016) Marjolein F Kluytmans–van den Bergh et al. Eurosurveillance
- Plasmid-mediated colistin resistance (mcr-1gene): three months later, the story unfolds
- (2016) Robert L. Skov et al. Eurosurveillance
- Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections
- (2016) Bradley J. Gardiner et al. Expert Review of Anti-Infective Therapy
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
- (2016) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B
- (2016) Alejandra Gallardo-Godoy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Early emergence of mcr-1 in Escherichia coli from food-producing animals
- (2016) Zhangqi Shen et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review
- (2016) Amee R. Manges et al. Infectious Diseases
- Combatting antimicrobial resistance globally
- (2016) Rebecca Sugden et al. Nature Microbiology
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
- (2015) Suzanne L. Parker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Klebsiella pneumoniae Carbapenemase Subtypes, Extended-Spectrum β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam against Carbapenem-Resistant K. pneumoniae
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of polymyxin susceptibility profile among KPC-producingKlebsiella pneumoniaeusing Etest and MicroScan WalkAway automated system
- (2015) Leandro Reus Rodrigues Perez APMIS
- Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals
- (2015) Christina A. Sutherland et al. CLINICAL THERAPEUTICS
- An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread
- (2015) V. Weterings et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae
- (2015) David van Duin et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China
- (2015) Yan Jiang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates
- (2015) Elizabeth B. Hirsch et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of anmgrBDeletion Mutant
- (2015) Tommaso Giani et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae
- (2015) J.-C. Lagier et al. JOURNAL OF HOSPITAL INFECTION
- Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
- (2015) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
- (2014) Kevin P. Connors et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
- (2014) Reem Almaghrabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment
- (2014) Antonio Cannatelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
- (2014) M. Monaco et al. Eurosurveillance
- Colistin resistance in Klebsiella pneumoniae
- (2014) Young-Mi Ah et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates
- (2014) Irene Pena et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
- (2014) M. Gonzalez-Padilla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany
- (2014) M. Kaase et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- (2013) George G. Zhanel et al. DRUGS
- Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
- (2013) Nicola Petrosillo et al. Expert Review of Anti-Infective Therapy
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
- (2013) Zakuan Z Deris et al. JOURNAL OF ANTIBIOTICS
- Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults
- (2013) Manjunath P. Pai JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece
- (2012) Irene Galani et al. JOURNAL OF CHEMOTHERAPY
- A Method for Generation Phage Cocktail with Great Therapeutic Potential
- (2012) Jingmin Gu et al. PLoS One
- Experimental Phage Therapy in TreatingKlebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in Mice
- (2011) Chih-Hsin Hung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
- (2011) N. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
- (2011) J. M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals
- (2011) M.L. Mezzatesta et al. CLINICAL MICROBIOLOGY AND INFECTION
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
- (2011) A. C. Gales et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria
- (2011) Ryan S. Arnold et al. SOUTHERN MEDICAL JOURNAL
- Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan
- (2010) Dror Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of acute kidney injury associated with intravenous colistin treatment
- (2010) Jeong-Ah Kwon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ACHN-490, a Neoglycoside with Potent In Vitro Activity Against Multidrug-Resistant Klebsiella pneumoniae Isolates
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008
- (2009) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now